Ruffo P, Traynor B, Conforti F
J Neurol. 2025; 272(3):233.
PMID: 40009238
PMC: 11865122.
DOI: 10.1007/s00415-025-12975-8.
Lazarou C, Moysidou E, Christodoulou M, Lioulios G, Sampani E, Dimitriadis C
Medicina (Kaunas). 2025; 61(2).
PMID: 40005378
PMC: 11857372.
DOI: 10.3390/medicina61020262.
Milena E, Maurizio M
Biomolecules. 2025; 15(2).
PMID: 40001586
PMC: 11852600.
DOI: 10.3390/biom15020284.
Parlati A, Madaudo C, Nuzzi V, Manca P, Gentile P, Di Lisi D
Card Fail Rev. 2025; 11:e01.
PMID: 39981305
PMC: 11836606.
DOI: 10.15420/cfr.2024.32.
Liu C, Kuo M, Kuo C, Wu I, Chen P, Hsu W
NPJ Aging. 2025; 11(1):7.
PMID: 39915530
PMC: 11802786.
DOI: 10.1038/s41514-025-00198-0.
Advancements in noninvasive techniques for transplant rejection: from biomarker detection to molecular imaging.
Song Y, Wang Y, Wang W, Xie Y, Zhang J, Liu J
J Transl Med. 2025; 23(1):147.
PMID: 39901268
PMC: 11792214.
DOI: 10.1186/s12967-024-05964-4.
Genetic Modifiers in Sickle Cell Disease Leg Ulcers: Unveiling the Pathways associated with the development and, or progression of Leg Ulcers - A Scoping Review Protocol.
Dogara L, Awwalu S, Awodele D
Niger Med J. 2025; 65(6):844-850.
PMID: 39877482
PMC: 11770651.
DOI: 10.60787/nmj.v65i6.628.
Electroencephalographic markers in Major Depressive Disorder: insights from absolute, relative power, and asymmetry analyses.
Ozcoban M, Tan O
Front Psychiatry. 2025; 15:1480228.
PMID: 39872429
PMC: 11770048.
DOI: 10.3389/fpsyt.2024.1480228.
Use of D-Squame as a Minimally Invasive Technique to Evaluate Skin Immune Response Biomarkers in Canine Atopic Dermatitis.
Mosca M, Milhau N, Legain M, Idee A, Langon X, Pin D
Vet Sci. 2025; 12(1.
PMID: 39852879
PMC: 11769324.
DOI: 10.3390/vetsci12010004.
Factors influencing salivary lactate dehydrogenase levels in oral squamous cell carcinoma and oral potentially malignant disorders.
Lopez-Pintor R, Gonzalez-Serrano J, Vallina C, Ivaylova Serkedzhieva K, Virto L, Nuevo P
Front Oral Health. 2025; 5():1525936.
PMID: 39839666
PMC: 11747469.
DOI: 10.3389/froh.2024.1525936.
Echocardiography of the right heart in pulmonary arterial hypertension: insights from the ULTRA RIGHT VALUE study.
Giudice F, Escribano-Subias P, Tello K, Kopec G, Ghio S, Giannakoulas G
Eur Heart J Imaging Methods Pract. 2025; 3(1):qyae121.
PMID: 39816928
PMC: 11733976.
DOI: 10.1093/ehjimp/qyae121.
Ammonia and beyond - biomarkers of hepatic encephalopathy.
Gallego J, Ballester M, Fiorillo A, Casanova-Ferrer F, Lopez-Gramaje A, Urios A
Metab Brain Dis. 2025; 40(1):100.
PMID: 39812958
PMC: 11735499.
DOI: 10.1007/s11011-024-01512-7.
Wide field imaging biomarkers: A different perspective.
Shiromani S, Pattathil N, Sadeghi E, Choudhry N, Chhablani J
Taiwan J Ophthalmol. 2025; 14(4):510-518.
PMID: 39803405
PMC: 11717343.
DOI: 10.4103/tjo.TJO-D-24-00125.
A mini review of leveraging biobanking in the identification of novel biomarkers in neurological disorders: insights from a rapid single-cell sequencing pipeline.
Miller J, Rose M, Roell J, Ubhe S, Liu T, Segal B
Front Neurosci. 2025; 18():1473917.
PMID: 39777270
PMC: 11703919.
DOI: 10.3389/fnins.2024.1473917.
Systematic Review of Sarcopenia Biomarkers in Hip Fracture Patients as a Potential Tool in Clinical Evaluation.
Brzeszczynski F, Hamilton D, Bonczak O, Brzeszczynska J
Int J Mol Sci. 2025; 25(24.
PMID: 39769198
PMC: 11679566.
DOI: 10.3390/ijms252413433.
The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma.
Koumpis E, Georgoulis V, Papathanasiou K, Papoudou-Bai A, Kanavaros P, Kolettas E
Biomedicines. 2025; 12(12.
PMID: 39767565
PMC: 11673977.
DOI: 10.3390/biomedicines12122658.
Subtype-specific prognostic impact of Bcl-2 in HER2-positive and HER2-negative breast cancer.
Kim T, Lim S, Choi H, Cho I, Noh H, Lee J
Sci Rep. 2025; 15(1):920.
PMID: 39762296
PMC: 11704137.
DOI: 10.1038/s41598-024-83302-w.
Application of machine learning for mass spectrometry-based multi-omics in thyroid diseases.
Che Y, Zhao M, Gao Y, Zhang Z, Zhang X
Front Mol Biosci. 2025; 11:1483326.
PMID: 39741929
PMC: 11685090.
DOI: 10.3389/fmolb.2024.1483326.
Comparative Prognostic Value of Glomerular Filtration Rate, Serum Cystatin C, Beta-2-Microglobulin and Albuminuria for Death and Chronic Kidney Disease Progression.
Cerezo I, Cancho B, Rodriguez Sabillon J, Jorge A, Alvarez Lopez A, Valladares J
J Clin Lab Anal. 2024; 39(2):e25139.
PMID: 39713962
PMC: 11776497.
DOI: 10.1002/jcla.25139.
Conceptual basis for the development of guidance for the use of biomarkers of effect in regulatory risk assessment of chemicals.
Hernandez-Jerez A, Bennekou S, Hoogenboom L, Mcardle H, Pieper C, Schwerdtle T
EFSA J. 2024; 22(12):e9153.
PMID: 39691503
PMC: 11650060.
DOI: 10.2903/j.efsa.2024.9153.
